Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Istaroxime PK/Safety in Healthy Chinese Volunteers
NCT02477449Phase 1Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Mar 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of istaroxime in Acute Heart Failure (AHF) (3 arms), sponsored by Lee's Pharmaceutical Holdings Limited. Primary endpoint: Safety of istaroxime at 1 week. Started Mar 2015; status: completed.
02
Drugs
istaroxime
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT02477449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02477449.